User menu

An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.

Bibliographic reference Osselaer, Jean-Claude ; Cazenave, J P ; Lambermont, M. ; Garraud, O. ; Hidajat, M ; et. al. An active haemovigilance programme characterizing the safety profile of 7437 platelet transfusions prepared with amotosalen photochemical treatment.. In: Vox sanguinis, Vol. 94, no. 4, p. 315-23 (2008)
Permanent URL http://hdl.handle.net/2078.1/11277
  1. van Rhenen D., Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial, 10.1182/blood-2002-03-0932
  2. McCullough J., Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial, 10.1182/blood-2003-12-4443
  3. Janetzko Karin, Cazenave Jean-Pierre, Kluter Harald, Kientz Daniel, Michel Martine, Beris Photis, Lioure Bruno, Hastka Jan, Marblie Stephane, Mayaudon Veronique, Lin Lily, Lin Jin-Sying, Conlan Maureen G., Flament Jocelyne, Therapeutic efficacy and safety of photochemically treated apheresis platelets processed with an optimized integrated set, 10.1111/j.1537-2995.2005.00550.x
  4. Osselaer J, Transfusion (2008)
  5. Garraud O, Vox Sang, 93, 32 (2007)
  6. Klein Harvey G., Anderson David, Bernardi Marie-Josée, Cable Ritchard, Carey William, Hoch Jeffrey S., Robitaille Nancy, Sivilotti Marco L.A., Smaill Fiona, Pathogen inactivation: making decisions about new technologies. : Report of a consensus conference, 10.1111/j.1537-2995.2007.01512.x
  7. Andreu Georges, Morel Pascal, Forestier Francois, Debeir Joelle, Rebibo Danielle, Janvier Gerard, Herve Patrick, Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998, 10.1046/j.1537-2995.2002.00202.x
  8. Faber JC, Blood Transfusion in Europe, 213 (2005)
  9. Corash L, Lin L, Novel processes for inactivation of leukocytes to prevent transfusion-associated graft-versus-host disease, 10.1038/sj.bmt.1704284
  10. Chambers LA, Kruskall MS, Pacini DG, Donovan LM, Febrile reactions after platelet transfusion: the effect of single versus multiple donors, 10.1046/j.1537-2995.1990.30390194340.x
  11. Heddle Nancy M., Klama Luba, Singer Joel, Richards Carl, Fedak Paul, Walker Irwin, Kelton John G., The Role of the Plasma from Platelet Concentrates in Transfusion Reactions, 10.1056/nejm199409083311001
  12. Mangano Mark M., Chambers Linda A., KruskalL Margot S., Limited Efficacy of Leukopoor Platelets for Prevention of Febrile Transfusion Reactions, 10.1093/ajcp/95.5.733
  13. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG, A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions, 10.1046/j.1537-2995.1993.331094054613.x
  14. Enright Helen, Davis Kathryn, Gernsheimer Terry, McCullough Jeffrey J., Woodson Robert, Slichter Sherrill J., Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial, 10.1046/j.1537-2995.2003.00529.x
  15. Isola H, Vox Sang, 93, 165 (2007)
  16. Kerkhoffs J.-L. H., Eikenboom J. C., Schipperus M. S., van Wordragen-Vlaswinkel R. J., Brand R., Harvey M. S., de Vries R. R., Barge R., van Rhenen D. J., Brand A., A multicenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma, 10.1182/blood-2006-04-020131
  17. de Wildt-Eggen J., Nauta S., Schrijver J.G., van Marwijk Kooy M., Bins M., van Prooijen H.C., Reactions and platelet increments after transfusion of platelet concentrates in plasma or an additive solution: a prospective, randomized study, 10.1046/j.1537-2995.2000.40040398.x
  18. Heddle Nancy M., Blajchman Morris A., Meyer Ralph M., Lipton Jeff H., Walker Irwin R., Sher Graham D., Constantini Lorrie A., Patterson Bruce, Roberts Robin S., Thorpe Kevin E., Levine Mark N., A randomized controlled trial comparing the frequency of acute reactions to plasma-removed platelets and prestorage WBC-reduced platelets, 10.1046/j.1537-2995.2002.00094.x